Flow Traders U.S.’s Invesco Dorsey Wright Healthcare Momentum ETF PTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,962
Closed -$351K 1005
2023
Q4
$351K Buy
8,962
+1,099
+14% +$36.8K 0.01% 574
2023
Q3
$264K Sell
7,863
-621
-7% -$23K 0.01% 645
2023
Q2
$344K Buy
+8,484
New +$338K 0.01% 606
2023
Q1
Sell
-6,585
Closed -$270K 1074
2022
Q4
$270K Sell
6,585
-1,500
-19% -$60.9K 0.01% 567
2022
Q3
$327K Sell
8,085
-72,951
-90% -$3.08M 0.02% 616
2022
Q2
$3.1M Sell
81,036
-4,410
-5% -$178K 0.17% 129
2022
Q1
$3.83M Buy
85,446
+55,278
+183% +$2.42M 0.13% 119
2021
Q4
$1.56M Sell
30,168
-9,456
-24% -$492K 0.08% 191
2021
Q3
$2.13M Buy
39,624
+26,541
+203% +$1.49M 0.09% 255
2021
Q2
$725K Sell
13,083
-17,001
-57% -$885K 0.04% 484
2021
Q1
$1.57M Buy
+30,084
New +$1.69M 0.09% 230
2020
Q4
Sell
-16,935
Closed -$767K 734
2020
Q3
$767K Buy
+16,935
New +$747K 0.06% 261

Other funds holding PTH

Flow Traders U.S.'s PTH Position: Q1 2024 in Review

Flow Traders U.S. sold out of Invesco Dorsey Wright Healthcare Momentum ETF (PTH) in Q1 2024, closing a stake of 8,962 shares — an estimated $351K sold.

Flow Traders U.S. first reported a position in PTH in Q3 2020 and held it in 12 quarters. The position peaked at $3.83M in Q1 2022. 71 funds tracked by Wall St. Rank hold PTH as of Q1 2024.

  • Flow Traders U.S. reported no remaining Invesco Dorsey Wright Healthcare Momentum ETF position as of Q1 2024 after selling out during the quarter.
  • Flow Traders U.S. sold 8,962 Invesco Dorsey Wright Healthcare Momentum ETF shares in Q1 2024, an estimated $351K.
  • Flow Traders U.S. first reported a position in Invesco Dorsey Wright Healthcare Momentum ETF in Q3 2020 and held it in 12 quarters.
  • Flow Traders U.S.'s Invesco Dorsey Wright Healthcare Momentum ETF position peaked at $3.83M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Invesco Dorsey Wright Healthcare Momentum ETF as of Q1 2024.

Based on Flow Traders U.S.'s 13F filing for Q1 2024, filed 15 May 2024.